US Stock MarketDetailed Quotes

Summit Therapeutics (SMMT)

Watchlist
  • 17.590
  • +0.420+2.45%
Close Oct 9 15:59 ET
  • 17.550
  • -0.040-0.23%
Post 19:58 ET
14.03BMarket Cap-15.85P/E (TTM)

Summit Therapeutics (SMMT) Earnings Dates, Reports & Conference Call

SMMT 2026 Q2 Estimated Earnings Dates & Summary

Currency:USDJul 23, 2026

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Net Income
-157.29M
-162.09M
-4.80M
Miss Est.
+62.72%
+61.58%
-3.05%
EPS
-0.218
-0.21
+0.008
Beat Est.
+61.50%
+62.88%
+3.57%
Buy

Oct 10, 2026

SMMT Revenue, EPS and EBIT Estimates

Revenue

Net Profit

EPS

EBIT

Revenue is based on 14 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: GBP

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2026/Q4-- / 2.986M--
--2026/Q3-- / 54.140K--
Jul 23, 20262026/Q20.000 / 0.000--
--2026/Q10.000 / 40.850K--
Feb 23, 20262025/Q40.000 / 56.783M--
DatePeriodRevenue/EstimateEarnings Call
--2026/Q4-- / 2.986M--
--2026/Q3-- / 54.140K--
Jul 23, 20262026/Q20.000 / 0.000--
--2026/Q10.000 / 40.850K--
Feb 23, 20262025/Q40.000 / 56.783M--

Unlock Free Earnings Estimates

Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On September 29, the U.S. and Iran continued indirect contacts through mediators, but core differences remain unresolved. Trump denied havin Show More